Compared with the no-treatment control group , patients receiving taVNS significantly differed in measures of FPG ( F ( @ ) = @ , p < @ ) , @hPG F ( @ ) = @ , p < @ ) and HbAlc ( F ( @ ) = @ , p = @ ) over the course of the @week treatment period .